| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $0 | -100.0% |
| SG&A Expense | $31K | -16.2% |
| Operating Income | -$31K | -4226.2% |
| Income Tax | $0 | — |
| Net Income | -$32K | +34.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Total Assets | $0 | -100.0% |
| Current Liabilities | $87K | +62.3% |
| Total Liabilities | $93K | +38.7% |
| Stockholders' Equity | -$93K | -52.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31K | +44.1% |
| Financing Cash Flow | $31K | -44.1% |